ID CMB HC.PH.BIO.CMB
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| KAKEN PHARMACEUTIAL CO., LTD. | 4521 | Japan | — | 535 |
| LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD. | 688739 | China | — | 534 |
| ANTEROGEN CO., LTD. | 065660 | South Korea | — | 523 |
| Biohaven Pharmaceutical Holding Co Ltd. Delisted | — | United States of America | — | 519 |
| Myovant Sciences Ltd. Delisted | — | United States of America | — | 516 |
| NeurogesX Inc Delisted | — | United States of America | — | 512 |
| SHANGHAI ALLIST PHARMACEUTICALS CO., LTD | 688578 | China | — | 502 |
| COLLAGENEX PHARMACEUTICALS INC Delisted | — | United States of America | — | 498 |
| CYTOGEN CORP Delisted | — | United States of America | — | 492 |
| IDM PHARMA, INC. Delisted | — | United States of America | — | 486 |
| Hualan Biological Vaccine Inc. | 301207 | China | — | 483 |
| Anesiva Inc Delisted | ANSV | United States of America | — | 482 |
| Acerus Pharmaceuticals Corporation Delisted | ASPCF | Canada | — | 480 |
| SHANGHAI MICURX PHARMACEUTICAL CO., LTD. | 688373 | China | — | 480 |
| Ocumension Therapeutics | 1477 | Cayman Islands | — | 479 |
| 三元基因 | 920344 | China | — | 471 |
| SpringWorks Therapeutics Inc Delisted | SWTX | United States of America | — | 470 |
| Spark Therapeutics Inc Delisted | ONCE | United States of America | — | 461 |
| GW Pharmaceuticals plc Delisted | GWPH | United States of America | — | 460 |
| Biopure Corp Delisted | BPURQ | United States of America | — | 446 |
| Kos Pharmaceuticals Inc Delisted | KOSP | United States of America | — | 444 |
| Kadmon Holdings Inc Delisted | KDMN | United States of America | — | 439 |
| Stemline Therapeutics Inc Delisted | STML | United States of America | — | 434 |
| 永顺生物 | 920729 | China | — | 431 |
| Loxo Oncology Inc Delisted | LOXO | United States of America | — | 429 |
| Ascentage Pharma Group International | 6855 | Hong Kong | — | 427 |
| Aimmune Therapeutics Inc Delisted | AIMT | United States of America | — | 425 |
| Viragen Inc Delisted | VRAI1 | United States of America | — | 425 |
| RVL Pharmaceuticals plc Delisted | — | Ireland | — | 424 |
| Pharmion Corp Delisted | PHRM | United States of America | — | 413 |
| Strongbridge Biopharma plc Delisted | — | United States of America | — | 412 |
| Alphamab Oncology | 9966 | Cayman Islands | — | 408 |
| Insys Therapeutics, Inc. Delisted | — | United States of America | — | 406 |
| NITROMED INC Delisted | — | United States of America | — | 404 |
| Checkpoint Therapeutics Inc Delisted | CKPT | United States of America | — | 395 |
| Relypsa Inc Delisted | — | United States of America | — | 379 |
| Tego Science, Inc. | 191420 | South Korea | — | 378 |
| TERCICA INC Delisted | — | United States of America | — | 377 |
| Antengene Corporation Limited | 6996 | Cayman Islands | — | 370 |
| Chiasma Inc Delisted | CHMA | United States of America | — | 370 |
| Neos Therapeutics Inc Delisted | NEOS | United States of America | — | 369 |
| Akeso, Inc. | 9926 | Cayman Islands | — | 365 |
| SEIKAGAKU CORPORATION | 4548 | Japan | — | 364 |
| CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD. | 688443 | China | — | 359 |
| ICOS CORP Delisted | — | United States of America | — | 357 |
| Baudax Bio Inc Delisted | BXRX | United States of America | — | 352 |
| Hyperion Therapeutics Inc Delisted | HPTX | United States of America | — | 349 |
| 2Seventy Bio Inc Delisted | TSVT | United States of America | — | 348 |
| *ST云大 Delisted | 600181 | China | — | 341 |
| Gamida Cell Ltd. Delisted | — | United States of America | — | 336 |
Other names for this activity, and where neighboring activities go instead.
No aliases listed.
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Also preclinical, drug developer
https://financialfilings.com/oics/CMB/
This page is keyed by the class ID CMB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.